Example: Heart Attack
Search clinical trials for: Alizapride
Total 1 results
-
NCT01636947CompletedConditions: Nausea, Vomiting
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Arthritis, Degenerative
- Attachment
- Characteristics Disease
- Hepassocin (Hepatocyte-derived Fibrinogen-related Protein 1)
- Impulsivity Aggression
- People With Impaired Motor Function in the Cervical Region
- Peripheral Arterial Disease, Angioplasty
- Sharp's Syndrome
- Sleeve Gastrectomy With Jejunoileal Anastomosis
- Stage IV Prostate Carcinoma
- Tooth Impacted
- Type 3 Spinal Muscular Atrophy
- Women Who Had at Lease One Cesarean Section in the Past
- View Full List
Sponsors and Collaborators
- AOMA Graduate School of Integrative Medicine
- Avidia
- Beacon Health Foundation
- Champlain Local Health Integration Network
- FriendsLearn Inc.
- Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
- Incyte Biosciences UK Ltd
- Jeju National University School of Medicine
- Kåre Håkansson
- Taipei Medical University Hospital
- University of Florida
- VoiceSense Ltd. Herzelba, Israel
- iReportoire Inc
- View Full List
Drug Interventions
- 5-Fluoruracil
- BAY 1238097
- Bacillus Calmette-Guérin (BCG)
- Budesonide 2 single doses, Metronidazole multiple-dose
- DFIL
- Recombinant staphylokinase
- Remifentanil + Lidocaïne
- Rosuvastatin 10mg → HL140 10/10
- Ruxolitinib 10 mg twice a day combined with Corticosteroids
- Tapentadol immediate release
- Vehicle Ointment
- Venlafaxine Hydrochloride Extended Release
- green apple
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations